Pierre Fabre Medicament - Supercritical Fluids Division: Press Releases
Pierre Fabre Médicament - SuperCritical Fluids Division to Exhibit at DDP 2012
Pierre Fabre Médicament - SuperCritical Fluids Division will be an exhibitor at DDP 2012 in Las Vegas (25-27...
Meet Pierre Fabre Médicament - SuperCritical Fluids Division - at CPhI Frankfurt 2011
Pierre Fabre Médicament - SuperCritical Fluids Division - proposes its expertise to external partners. This unit uses supercritical fluids for: Pre-formulation (coating, complexation...
Pierre Fabre Médicament: A cGMP Supercritical Fluids Unit at AAPS Annual Meeting and Exposition in Washington DC
AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. This year Pierre Fabre Médicament -...
Pierre Fabre Medicament Provides New Technology for the Cleaning of Medical Devices
Pierre Fabre Medicament explains the advantages of using supercritical CO2 technology for cleaning. Already well known for its pre-formulation solutions permitting the increase...
Pierre Fabre Médicament Presents the Advantages of a New Coating Process: FORMULCOAT®
Pierre Fabre Médicament has an extensive expertise in supercrititical fluids and has developed a new coating process called FORMULCOAT®. This process gives a performing taste-masking...
Meet Pierre Fabre Médicament - Supercritical Fluids Division in 2011
Pierre Fabre Médicament - Supercritical Fluids Division, a unit of Pierre Fabre Médicament, the second independent pharmaceutical French laboratory, is pleased to announce that it will...
Innovative Formulations at the AAPS Annual Meeting in New Orleans
From 15 to 17 November 2010, Pierre Fabre Medicament will be exhibiting at the AAPS annual meeting in the Morial Convention Centre in New Orleans, Louisiana, US. Do you have critical problems...
PFM - Supercritical Fluids Division to Exhibit at CPhI Japan 2010
From 21 to 23 April 2010, Pierre Fabre Medicament will be exhibiting at CPhI Japan 2010 in Tokyo, at the Tokyo Big Sight Exhibition Centre. Interested in our extensive expertise in...
Pierre Fabre Medicament : Exhibitor at CPhI Worldwide Madrid 2009
From 13-15 October 2009, Pierre Fabre Medicament will be exhibiting at CPhI Worldwide 2009 in Madrid. Interested in our extensive expertise in supercritcal fluids focused on the development...
Pierre Fabre Medicament: Exhibitor at CPhI South America 2009, Sao Paulo, from 26 August to 28 August
Pierre Fabre Medicament will exhibit at CPhI South America 2009, which will be held from 26 August to 28 August in Sao Paulo's Transamerica Expo Center, Brazil. The supercritical fluids...
Pierre Fabre Medicament to Exhibit at Controlled Release Society 2009
Pierre Fabre Medicament will exhibit at Controlled Release Society 2009, which will be held from 20 July to 22 July in Copenhagen's Bella Center, Denmark. The supercriticalfluids division...
Supercritical Fluids Division: Exhibitor at CPhI Japan 2009.
Pierre Fabre Medicament will exhibit at CPhI Japan 2009, which will be held on 21-23 April 2009 at Tokyo Big Sight Exhibition Center. Our supercritical fluids division will present its...
Supercritical Fluids Division: Exhibitor at AAPS Atlanta 2008
Pierre Fabre Medicament will exhibit at AAPS Atlanta 2008, which will be held between the 16th and the 20th of November 2008. Our supercritical fluids division will present its updated...
Conference on Bioavailability Enhancement by a Supercritical Process
Dr Hubert Lochard, R&D Project Manager, will give a conference at Dissolution Testing, Bioavailability & Bioequivalence organised by Informa on November, 21st in Berlin. The topic of...
Patented Drug Delivery Technologies: FORMULPLEX and FORMULCOAT
Based on our know-how in supercritical fluids, we have developed a multi-purpose technology platform. Today, three main technologies are available from development to commercial...
Stabilization, Protection and Taste Masking of APIs
Pierre Fabre Medicament (active ingredients division) will be participating in the following events : Strategies to Enhance Solubility, Permeability and Absorption of Drugs,...
Innovative Coating Technology - SuperCritical Fluids
Pierre Fabre Medicament - active ingredient division - has recently enlarged its Drug Delivery Technology portfolio based on its knowledge in SuperCritical Fluids. This...
Natural Product Extraction and Purification - Botanical Drug Substance
Pierre Fabre Medicament - active ingredients division - will be attending Natural Products in Drug Discovery & Development on the 21-22 June 2006 in London. Based on 40...
Solubility Enhancement of a Poorly Soluble API
Pierre Fabre Medicament - active ingredients division - will be exhibiting at INFORMEX (Stand #1342) and will give two presentations on the 14th of February : 11:20 am - 11:40 am...
Development Of Poorly-Soluble APIs
On the occasion of CPhI, Pierre Fabre Medicament, Active Ingredients Division, will present its innovative technology enabling the development of poorly-soluble APIs. PFM has developed an...
Dramatic bioavailability increase of API in SuperCritical medium.
Dramatic bioavailability increase of API in SuperCritical medium. Plantes & Industrie, development and manufacturing site of Pierre Fabre Group, has published an article in the April issue...
Bioavailability Enhancement of APIs Using SuperCritical CO2
Plantes & Industrie, the development and manufacturing site of Pierre Fabre Group, has successfully launched its two new state-of-the-art development and production units. These facilities...
Twitter